Rainbow Extension Study

Clinical trial NCT02640664 · COMPLETED

Trial details

NCT number: NCT02640664
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Retinopathy of Prematurity (ROP)

Start date: 2016-06-16
Primary completion: 2022-04-21
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.